Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.76 USD | +3.58% | -2.84% | -34.15% |
11/03 | AbCellera, Biogen Collaborate to Discover Treatments for Neurological Diseases | MT |
11/03 | AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions | CI |
Sales 2024 * | 47.81M 3.99B | Sales 2025 * | 64.33M 5.36B | Capitalization | 1.1B 91.79B |
---|---|---|---|---|---|
Net income 2024 * | -190M -15.84B | Net income 2025 * | -219M -18.26B | EV / Sales 2024 * | 19.2 x |
Net cash position 2024 * | 183M 15.28B | Net cash position 2025 * | 79.31M 6.61B | EV / Sales 2025 * | 15.9 x |
P/E ratio 2024 * |
-6.21
x | P/E ratio 2025 * |
-6.04
x | Employees | 586 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.9% |
Latest transcript on AbCellera Biologics Inc.
1 day | +3.58% | ||
1 week | -2.84% | ||
Current month | -17.00% | ||
1 month | -12.35% | ||
3 months | -29.32% | ||
6 months | -9.18% | ||
Current year | -34.15% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 39 | 08/12/08 | |
Founder | - | 08/12/08 | |
Carl Lars Hansen
CEO | Chief Executive Officer | 49 | 08/12/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Montalbano
BRD | Director/Board Member | 59 | 01/20/01 |
Michael Hayden
BRD | Director/Board Member | 72 | 01/19/01 |
Andrew Lo
BRD | Director/Board Member | 63 | 07/21/07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.19% | 0 M€ | 0.00% | - | |
0.18% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +6.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 3.76 | +3.58% | 1,369,561 |
25/24/25 | 3.63 | -6.92% | 1,829,913 |
24/24/24 | 3.9 | -1.76% | 1,599,075 |
23/24/23 | 3.97 | -1.00% | 1,595,129 |
22/24/22 | 4.01 | +3.62% | 1,076,281 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.15% | 1.1B | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ABCL Stock